Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
SMCAZ: Azithromycin added to Seasonal Malaria Chemoprevention
NCT02211729Phase 3Completed
- Sponsor
- London School of Hygiene & Tropical Medicine
- Start
- May 2014
- Primary completion
- Dec 2017
- Modality
- Small Molecules
- Countries
- 2
01
Overview
A Phase 3 trial of azithromycin in malaria, respiratory tract infection (RTI), sponsored by London School of Hygiene & Tropical Medicine. Started May 2014; status: completed.
02
Drugs
azithromycin
03
Conditions
malariarespiratory tract infection (RTI)
Beyond the preview
Go deeper on NCT02211729.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT02211729.